These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 1435363

  • 21. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K, Jakoniuk P, Sacha PT, Zalewska M, Wieczorek P.
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
    Mégraud F, Gavinet A.
    Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
    Wu YL, Scott EM, Po AL, Tariq VN.
    APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The resistance to betalactam antibiotics of lactose-positive and lactose-negative strains of Escherichia coli.
    Janicka G, Wojciechowska D, Hareńska K, Porada J, Kłyszejko C.
    Acta Microbiol Pol; 1997 Jun; 46(4):399-403. PubMed ID: 9516987
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of resistance to antimicrobials of Escherichia coli isolates from clinical sources at a private hospital in Trinidad.
    Orrett FA, Shurland SM.
    Jpn J Infect Dis; 2001 Apr; 54(2):64-8. PubMed ID: 11427743
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
    Dance DA, Wuthiekanun V, Chaowagul W, Suputtamongkol Y, White NJ.
    J Antimicrob Chemother; 1991 Aug; 28(2):321-4. PubMed ID: 1723404
    [No Abstract] [Full Text] [Related]

  • 36. Monitoring bacterial resistance to restricted antibiotics.
    Grunt J, Krcméry V, Rosival L.
    Am J Hosp Pharm; 1978 Nov; 35(11):1387-9. PubMed ID: 101082
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
    Aguilar L, Martín M, Balcabao IP, Gómez-Lus ML, Dal-Ré R, Prieto J.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.